Stay updated on Pembrolizumab Combo in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    No significant changes were detected in core study details; observed updates seem limited to formatting or UI adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T11:58:04.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Added related topics Lung cancer and MedlinePlus Genetics to the study page. These additions provide quick access to disease context and genetics information.
    Difference
    0.1%
    Check dated 2025-10-27T08:41:23.000Z thumbnail image
  3. Check
    32 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    3%
    Check dated 2025-10-05T17:20:09.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Add Lung Cancer topics under MedlinePlus and Genetics, and update revision to v3.1.0; remove older related topics and revert to v3.0.2.
    Difference
    0.5%
    Check dated 2025-09-28T10:09:07.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Removed a MedlinePlus Genetics topic on Lung cancer. No new topics added to replace it.
    Difference
    0.2%
    Check dated 2025-09-21T06:42:13.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; 'Back to Top' link removed.
    Difference
    0.2%
    Check dated 2025-09-14T00:20:18.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page.